Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)

作者: José Belderbos , Lon Uitterhoeve , Nico van Zandwijk , Huub Belderbos , Patrick Rodrigus

DOI: 10.1016/J.EJCA.2006.09.005

关键词: CarcinomaNuclear medicineGemcitabineRadiation therapyCisplatinPneumonitisLung cancerSurvival analysisInternal medicineGastroenterologyRespiratory diseaseMedicine

摘要: A randomised phase III study was performed comparing sequential (S) and concurrent (C) chemo-radiotherapy (CRT) in non-small cell lung cancer (NSCLC) patients. Methods : One hundred fifty-eight patients were to receive two courses of Gemcitabine (1250 mg/m2 days 1, 8) Cisplatin (75 day 2) prior to, or daily low-dose (6 mg/m2) with radiotherapy, consisting 24 fractions 2.75 Gy 32 days, a total dose 66 Gy. Results Acute haematological toxicity grade 3/4 more pronounced the (30% versus 6%), oesophagitis frequent arm (5% 14%). Late 3 4% (S C), pneumonitis 14% 18% (C). Because poor power no significant differences median survival (MS), overall (OS) progression-free (PFS) could be detected. MS 16.2 16.5 months, 2-year OS 34% 39% (C), 3-year 22% Conclusion Radiotherapy given concurrently after Gemcitabine/Cisplatin well tolerated. Due early closure conclusions can reached on relative merits; both arms showed good OS.

参考文章(25)
Noelle O'Rourke, Marta Roqué i Figuls, Nuria Farré Bernadó, Fergus Macbeth, Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database of Systematic Reviews. ,(2010) , 10.1002/14651858.CD002140.PUB3
Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara, Hideki Nishikawa, Yoshiki Takada, Shinzoh Kudoh, Nobuyuki Katagami, Yutaka Ariyoshi, Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2692- 2692 ,(1999) , 10.1200/JCO.1999.17.9.2692
John A Green, John M Kirwan, Jayne F Tierney, Paul Symonds, Lydia Fresco, Mandy Collingwood, Christopher J Williams, Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis The Lancet. ,vol. 358, pp. 781- 786 ,(2001) , 10.1016/S0140-6736(01)05965-7
A.L.J. Uitterhoeve, J.S.A. Belderbos, M.G.J. Koolen, P.J.M. van der Vaart, P.T.R. Rodrigus, J. Benraadt, C.C.M. Koning, D. González González, H. Bartelink, Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study European Journal of Cancer. ,vol. 36, pp. 592- 600 ,(2000) , 10.1016/S0959-8049(99)00315-9
David Ball, James Bishop, Jennifer Smith, Peter O'Brien, Sidney Davis, Gail Ryan, Ian Olver, Guy Toner, Quenten Walker, David Joseph, A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiotherapy and Oncology. ,vol. 52, pp. 129- 136 ,(1999) , 10.1016/S0167-8140(99)00093-6
Petr Zatloukal, Lubos Petruzelka, Milada Zemanova, Libor Havel, Filip Janku, Libor Judas, Antonin Kubik, Evzen Krepela, Pavel Fiala, Ladislav Pecen, Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study Lung Cancer. ,vol. 46, pp. 87- 98 ,(2004) , 10.1016/J.LUNGCAN.2004.03.004
T. Le Chevalier, G. Scagliotti, R. Natale, S. Danson, R. Rosell, R. Stahel, P. Thomas, R.M. Rudd, J. Vansteenkiste, N. Thatcher, C. Manegold, J.-L. Pujol, N. van Zandwijk, C. Gridelli, J.P. van Meerbeeck, L. Crino, A. Brown, P. FitzGerald, M. Aristides, J.H. Schiller, Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer. ,vol. 47, pp. 69- 80 ,(2005) , 10.1016/J.LUNGCAN.2004.10.014
Lucio Crinò, Cesare Calandri, Gemzar platinum combinations: phase III trials in non-small cell lung cancer. Lung Cancer. ,vol. 38, pp. 9- 12 ,(2002) , 10.1016/S0169-5002(02)00351-3
H Bartelink, J.H.M Schellens, M Verheij, The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. European Journal of Cancer. ,vol. 38, pp. 216- 222 ,(2002) , 10.1016/S0959-8049(01)00363-X